Over time, certain enzymes break down collagen and proteoglycans, the structural proteins that give cartilage its cushioning capacity. A2M is one of the few naturally occurring molecules capable of neutralizing multiple protease types simultaneously, which is why its depletion in arthritic joints is considered clinically significant.
What separates A2M therapy from most regenerative options is its protective mechanism. Many treatments focus on stimulating repair in tissue that may no longer have sufficient cellular resources to respond. A2M works differently by interrupting the breakdown process before the damage deepens. For patients in early to moderate stages of joint degeneration, intervening at that stage can mean the difference between preserving function and losing it.
Concentration matters. The A2M levels circulating in standard blood are not high enough to produce a therapeutic effect at the joint. Processing isolates and amplifies that concentration before precise delivery to the target site. Curious whether your condition qualifies? Contact St. Clair Seals Regenerative Wellness to schedule your evaluation.